Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features
about
Genetics of Human and Canine Dilated CardiomyopathyIon Channels in the HeartA network-oriented perspective on cardiac calcium signalingCardiac disease and arrhythmogenesis: Mechanistic insights from mouse modelsThe cardiac conduction systemThe RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading framInherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesisCalmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice.Ca²⁺-dependent phosphorylation of Ca²⁺ cycling proteins generates robust rhythmic local Ca²⁺ releases in cardiac pacemaker cells.Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.Clinical characteristics and mutational analysis of the RyR2 gene in seven Czech families with catecholaminergic polymorphic ventricular tachycardia.A family with recurrent sudden death and no clinical clue.Genetic analysis of Iranian family with hereditary cardiac arrhythmias by next generation sequencing.Cardiac aging and heart disease in humansA coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker.Pharmacological changes in cellular Ca2+ homeostasis parallel initiation of atrial arrhythmogenesis in murine Langendorff-perfused hearts.Mechanisms of sinoatrial node dysfunction in a canine model of pacing-induced atrial fibrillation.Tachybradycardia in the isolated canine right atrium induced by chronic sympathetic stimulation and pacemaker current inhibition.Acute atrial arrhythmogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts.The role of the calcium and the voltage clocks in sinoatrial node dysfunction.Potential effects of intrinsic heart pacemaker cell mechanisms on dysrhythmic cardiac action potential firingGeneration and characterization of a mouse model harboring the exon-3 deletion in the cardiac ryanodine receptor.Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1.Array comparative genomic hybridization identifies a heterozygous deletion of exon 3 of the RYR2 geneAbnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathiesWhat keeps us ticking: a funny current, a calcium clock, or both?Ryanodine receptor cluster fragmentation and redistribution in persistent atrial fibrillation enhance calcium release.Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles.Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.Abnormal Ca(2+) homeostasis, atrial arrhythmogenesis, and sinus node dysfunction in murine hearts modeling RyR2 modificationThe renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmiasImplantable cardioverter-defibrillator implantation in a patient with atrial standstillEvolving molecular diagnostics for familial cardiomyopathies: at the heart of it allPacemaker gene mutations, bradycardia, arrhythmias and the coupled clock theory.Regulation of basal and reserve cardiac pacemaker function by interactions of cAMP-mediated PKA-dependent Ca2+ cycling with surface membrane channels.Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.Mapping cardiac pacemaker circuits: methodological puzzles of the sinoatrial node optical mapping.The genetic and clinical features of cardiac channelopathies.Common variants for atrial fibrillation: results from genome-wide association studies.
P2860
Q26798712-1EAAC0F1-9209-439B-973D-26FE2FC52929Q26829681-9F2DE49C-3916-4AA3-814D-2028B981C3DCQ27023389-0515C027-2E31-4A0F-A01C-75D86D81EF09Q28066019-4B45AC23-BEB4-4E65-9EE7-FC2C3E810AE3Q28116242-B7B1F087-2AF4-4602-BFE8-8439EBF848D0Q28265202-454944C4-82D2-4E89-A7B9-AB61530231B1Q28308142-29B0D36B-5C6E-4B91-B661-1267C2051648Q30488460-2BD5573E-2E3F-4A62-8A2A-66BAEFEAB346Q30659905-59CF79B9-E8AE-4398-8352-AEDDEAF31476Q33157114-D6005561-B2E4-4F41-A912-71E92DA9CEBAQ33161218-0A701D41-F874-49D0-BAE7-A710811A4BBBQ33161934-458488C9-CC8F-46BC-A7D9-639E3645479FQ33167089-5853A048-D19D-4674-AEA2-00A60BAB0EBBQ33639771-B9AC3F14-81A7-481E-9ED6-30EF59A4FAE1Q33722486-827D769A-35C7-4DDB-930E-3B75A2BA60E5Q33739827-AAFD8C00-7BE1-48FF-8D2D-E7BB7BF1B49FQ34079072-0C143D6B-E4FC-40B8-BD12-653BB19FCD09Q34150582-7E9A4E25-BAD5-490C-99EC-EC02C6A90005Q34575281-8196F95D-051A-4356-B3CF-49901F37BC53Q34635508-D6206F30-3BE6-4958-B440-F9B6F5DC5D1AQ35110428-B26A440A-9E1F-4738-94B6-F64B623CF6B7Q35152139-A19E8FDD-2FA7-422F-A94E-75169A148D28Q35176492-7AD96792-A97E-4D0B-90A2-53BD15ED1458Q35922149-2039DB29-A040-402E-A012-62590236E554Q35936858-3E5A5FC0-2BB0-40F5-B0A9-9F8664636B2FQ36010630-4DCA6D51-1B7E-4EB4-A00F-431E7581DC5BQ36287960-D66441C4-D1A1-4318-8BE8-DE22466E22ECQ36452297-E78C5700-124B-43DF-B0CC-418F25CD2495Q36688514-2F0D048C-22C9-457F-8DAF-4076D4AF1972Q36696236-DA943539-6B7F-454C-B9EB-43EB90A17CE0Q36952000-8CEA3855-0951-4015-8D64-44EE88BF3285Q37011175-0C2E7A1D-D4DF-4F26-B8CD-01294D83A669Q37114030-C46CE264-B856-4E46-823B-C1DBA8746B93Q37255253-5CA95C00-9316-4CA5-8119-358B78BB26D9Q37373390-F48223C6-498A-42FC-A7C5-525022CB58E6Q37377209-608F0BD5-422C-432B-BE88-148D5D2AFD95Q37521378-28AAE0A4-1405-40DD-9A51-84B246C6311AQ37687714-A68AB664-EEA0-429D-AC3B-04E449F0BE7BQ37770572-E54964BB-BDE4-4C78-8F5C-A7ACE521EBE1Q37898563-B7E6969F-6C80-4FEA-95FF-C76C0447B5DA
P2860
Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Expanding spectrum of human RY ...... ructural, and genetic features
@ast
Expanding spectrum of human RY ...... ructural, and genetic features
@en
Expanding spectrum of human RY ...... ructural, and genetic features
@en-gb
Expanding spectrum of human RY ...... ructural, and genetic features
@nl
type
label
Expanding spectrum of human RY ...... ructural, and genetic features
@ast
Expanding spectrum of human RY ...... ructural, and genetic features
@en
Expanding spectrum of human RY ...... ructural, and genetic features
@en-gb
Expanding spectrum of human RY ...... ructural, and genetic features
@nl
prefLabel
Expanding spectrum of human RY ...... ructural, and genetic features
@ast
Expanding spectrum of human RY ...... ructural, and genetic features
@en
Expanding spectrum of human RY ...... ructural, and genetic features
@en-gb
Expanding spectrum of human RY ...... ructural, and genetic features
@nl
P2093
P921
P3181
P1433
P1476
Expanding spectrum of human RY ...... ructural, and genetic features
@en
P2093
Ans C P Wiesfeld
Irene van Langen
J Peter van Tintelen
Maarten P van den Berg
Marcel M A M Mannens
Margreet T E Bink-Boelkens
Marielle Alders
Zahurul A Bhuiyan
P304
P3181
P356
10.1161/CIRCULATIONAHA.107.711606
P407
P577
2007-09-17T00:00:00Z